Cite
HARVARD Citation
Metzenmacher, M. et al. (2021). A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer. Therapeutic advances in medical oncology. p. . [Online].